Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles

ZIOPHARM Presents Positive Darinaparsin Clinical Data At ASCO's Prestigious Clinical Science Symposium
ZIOPHARM Oncology, Inc. (Nasdaq: ZIOP) announced today that it presented positive data from both Phase II intravenous (IV) and Phase I oral studies of darinaparsin (ZinaparTM or ZIO-101), the novel organic arsenic molecule, as part of the prestigious Clinical Cancer Symposia at the 45th Annual American Society of Clinical Oncology (ASCO) meeting held in Orlando, FL, May 29th to June 2nd.

JDRF Launches Innovative Cure Collaboration Partnership With Sanford Health
The Juvenile Diabetes Research Foundation International, the world"s leading charitable funder and advocate of diabetes research, said that it is partnering with Sanford Health, an integrated health care system in South Dakota and the Midwest, in an innovative "cure collaboration" to speed the pace of diabetes research and delivery of cures at the point-of-care.
News of the day
1957-58 Flu Pandemic Can Provide Clues To Planning For H1N1
As the U.S. prepares for a resurgence of H1N1 influenza this fall, much can be learned from looking at a previous pandemic that had similar patterns. In an article published today in Biosecurity and Bioterrorism, researchers at the Center for Biosecurity of the University of Pittsburgh Medical Center (UPMC) examined historical documents, published material, and newspaper coverage related to the 1957-58 influenza pandemic to compare the progress and severity of that outbreak with the current one. The simple, practical actions taken in 1957 allowed the country to continue functioning with minimal disruption.
Endocrinology

Study Suggests Smoking May Worsen MS

A new study has revealed a possible link between smoking and more rapid progression of disability in multiple sclerosis (MS). The journal Archives of Neurology yesterday reported the results of a Boston study that examined 1465 people with MS over three years. The study, carried out at the Harvard Medical School, divided participants into three groups: those who had never smoked, ex-smokers and current smokers. The results showed that people with MS who already smoked had significantly increased disability at the beginning of the study and were more likely to have primary progressive MS. Furthermore, the study found that current smokers were more than twice as likely to progress from relapsing remitting MS to secondary progressive MS in the time that the study was being conducted. MRI scans also revealed that the number of lesions increased in the group of participants that smoked compared with the non-smoking group of participants. Dr Susan Kohlhaas, Research Communications Officer at the MS Society said: "The study suggests that cigarette smoke may influence progression of MS, but other environmental factors that may be linked to MS are not considered in this study. These will need to be looked at in more detail before firm conclusions can be drawn about the role of smoking in MS." For a breakdown of study results, see Research News. Multiple Sclerosis Society


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009